Across TCGA pan-cancer cohorts, ZNF736P11Y RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated ZNF736P11Y data layer.
The strongest signal is observed in thyroid carcinoma (THCA), where higher ZNF736P11Y RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ZNF736P11Y expression acts as an unfavorable survival marker.
THCA are the cancer types where ZNF736P11Y RNA most reproducibly stratifies survival.